The first look-in when comes "which I believe is now" will be PR'd to investors. The company knows this is a major milestone for SUNRISE and the company also knows the investment community is waiting to hear it.
The first look-in and data from the Yervoy combo melanoma trial are the two milestones which prospective partners have been waiting on.
We common investors have not heard any of this today because these milestones have been used to finalize a partnership which I believe will be similar to the deal PCYC had with J&J. In my opinion BMY is our suitor.
BMY in my opinion will fund the new trials with large milestone payments at trial inflection points.
Thanks for the endless repeat. I wish I had the time to read all previous posts but I do have a day job.
Either way it's not a material event but I'm sure the company would love nothing more than to release information as they see fit. If it's positive I'm sure it will be PR'd as the company sees we are waiting with baited breath.
News 
Market Data 
Discover 
